Effects of reversible inhibition of cholinesterase and nicotine on mouse mortality and blood levels of proinflammatory cytokines during the early phase of sepsis

Bull Exp Biol Med. 2012 Mar;152(5):600-2. doi: 10.1007/s10517-012-1585-z.
[Article in English, Russian]

Abstract

Experiments on outbred albino mice have shown that proserine (reversible cholinesterase inhibitor) and nicotine (nicotinic receptor agonist) in a equivalent dose of 0.2 DL(50)injected 2 h before sepsis induction significantly reduced animal mortality from experimental infection due to reduction of blood concentrations of proinflammatory cytokines TNF-α, IL-1β, and IL-6.

MeSH terms

  • Animals
  • Animals, Outbred Strains
  • Cholinesterase Inhibitors / administration & dosage*
  • Drug Therapy, Combination
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development
  • Escherichia coli Infections / drug therapy*
  • Escherichia coli Infections / immunology
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / mortality
  • Female
  • Interleukin-1beta / blood
  • Interleukin-1beta / immunology
  • Interleukin-6 / blood
  • Interleukin-6 / immunology
  • Male
  • Mice
  • Neostigmine / administration & dosage*
  • Nicotine / administration & dosage*
  • Nicotinic Agonists / administration & dosage*
  • Sepsis / drug therapy*
  • Sepsis / immunology
  • Sepsis / microbiology
  • Sepsis / mortality
  • Survival Rate
  • Time Factors
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Cholinesterase Inhibitors
  • Interleukin-1beta
  • Interleukin-6
  • Nicotinic Agonists
  • Tumor Necrosis Factor-alpha
  • Neostigmine
  • Nicotine